LGALS9 Human His
目录号 : GC27254Galectin-9/LGALS9 蛋白充当嗜酸性粒细胞趋化剂，招募和迁移嗜酸性粒细胞，这是炎症反应中的关键免疫细胞。它还充当血管生成抑制剂，调节血管形成并影响血管过程。Galectin-9/LGALS9 作为调节剂发挥作用，抑制自然杀伤细胞产生干扰素-γ (IFNG)，从而控制免疫信号通路。Galectin-9/LGALS9 蛋白, Human (HEK293, His) 是重组的 Galectin-9/LGALS9 蛋白，由 HEK293 表达，带有 C-6*His 标签。
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
Galectin-9/LGALS9 蛋白可作为嗜酸性粒细胞趋化剂，积极参与嗜酸性粒细胞的招募和迁移，嗜酸性粒细胞是参与炎症反应的关键免疫细胞。此外，它还作为血管生成抑制剂，有助于调节血管形成并影响血管过程。Galectin-9/LGALS9 作为免疫反应的调节剂，可抑制自然杀伤细胞产生干扰素-γ (IFNG)，从而控制免疫信号通路（通过相似性）。
| Purity | Greater than 95% as determined by reducing SDS-PAGE. | Source | HEK293 |
| Phycical Appearance | Lyophilized powder | Shipping Condition | Room temperature in continental US; may vary elsewhere. |
| Synonyms | Galectin-9; Gal-9; Ecalectin; Tumor Antigen HOM-HD-21; LGALS9 | ||
| Amino Acid Sequence | MAFSGSQAPYLSPAVPFSGTIQGGLQDGLQITVNGTVLSSSGTRFAVNFQTGFSGNDIAFHFNPRFEDGGYVVCNTRQNGSWGPEERKTHMPFQKGMPFDLCFLVQSSDFKVMVNGILFVQYFHRVPFHRVDTISVNGSVQLSYISFQPPGVWPANPAPITQTVIHTVQSAPGQMFSTPAIPPMMYPHPAYPMPFITTILGGLYPSKSILLSGTVLPSAQRFHINLCSGNHIAFHLNPRFDENAVVRNTQIDNSWGSEERSLPRKMPFVRGQSFSVWILCEAHCLKVAVDGQHLFEYYHRLRNLPTINRLEVGGDIQLTHVQT | ||
| Apparent Molecular Weight | Approximately 43-55 kDa due to the glycosylation. | ||
| Stability | Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage. | ||
| Endotoxin Level | <1 EU/μg, determined by LAL method. | ||
| Reconstitution | It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O. | ||
| Formulation | Lyophilized from a 0.2 μm filtered solution of 50 mM MOPS, 150 mM NaCl, 1 mM DTT, 1 mM EDTA, 5% Trehalose, pH 7.4 or PBS, pH 7.4, 5 mM DTT, 1mM EDTA, 8% trehalose or 20 mM His-HCl, 8% Trehalose, 2% Mannitol, 0.05% Tween 80, 1 mM EDTA, 1mM DTT, pH 6.0 or P | ||
Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.